Lucie Berkovitch
banner
lucieberko.bsky.social
Lucie Berkovitch
@lucieberko.bsky.social
MD. PhD. Psychiatrist and researcher at GHU Paris psychiatrie & neurosciences - Psychedelics, consciousness and psychiatry
" #Ketamine disrupts #consciousness in healthy participants in relation with #psychotic-like symptoms"

🥸 This is the title of our last preprint @biorxiv-neursci.bsky.social giving some insights on how ketamine at subanesthetic doses mimicks psychosis symptoms!

www.biorxiv.org/content/10.1...
Ketamine disrupts consciousness in healthy participants in relation with psychotic-like symptoms
Ketamine is an NMDA-receptor antagonist, which alters the state of wakeful consciousness at high doses. At lower doses, it induces reversible psychotic-like symptoms and has been used as a pharmacolog...
www.biorxiv.org
November 13, 2025 at 7:18 PM
🎙️ I am very proud to have participated (with a very strong French accent) to the BBC Radio 4 program Understand entitled "The Trip", about the science, culture, history and future of psychedelics 🌈

www.bbc.co.uk/programmes/m...
September 12, 2025 at 3:29 PM
Reposted by Lucie Berkovitch
A few moments from our ongoing MESEC 2025 Workshop (‘Centering Experience in Mental Health: Uniting Psychiatry and Consciousness Science’) at the beautiful Lago di Bolsena!

@lucieberko.bsky.social
@tehseennoorani.bsky.social
September 4, 2025 at 8:31 AM
Reposted by Lucie Berkovitch
🚨 New article in #NCONSC

Disruption of consciousness depends on insight in obsessive-compulsive disorder and on positive symptoms in schizophrenia
academic.oup.com/nc/article/2...

@lucieberko.bsky.social

#consciousness
🧠🧪
Disruption of consciousness depends on insight in obsessive-compulsive disorder and on positive symptoms in schizophrenia
Abstract. Disruption of conscious access contributes to the advent of psychotic symptoms in schizophrenia and could also explain lack of insight in other p
academic.oup.com
August 26, 2025 at 10:06 PM
🗞️ First article as #lastauthor published in Neuroscience of Consciousness @nconsc.bsky.social 🥳 🥳 🥳

academic.oup.com/nc/article/d...

🔍 In this study, we examine how #consciousness disruption translates into clinical manifestations in different #psychiatric disorders. 🧶⤵️
Disruption of consciousness depends on insight in obsessive-compulsive disorder and on positive symptoms in schizophrenia
Abstract. Disruption of conscious access contributes to the advent of psychotic symptoms in schizophrenia and could also explain lack of insight in other p
academic.oup.com
September 3, 2025 at 10:04 AM
New paper out in Psychological Medicine where we found that #sertraline and #placebo strikingly induce a similar clinical improvement predicted by distinct neural configurations!

doi.org/10.1017/S003...
A common symptom geometry of mood improvement under sertraline and placebo associated with distinct neural patterns | Psychological Medicine | Cambridge Core
A common symptom geometry of mood improvement under sertraline and placebo associated with distinct neural patterns - Volume 55
doi.org
August 16, 2025 at 10:43 AM
📚 Just another #review about #psychedelics? Maybe... but in this paper we systematically reviewed ALL neuroimaging articles involving #psilocybin intake in humans.
www.sciencedirect.com/science/arti...
Neurocognitive effects of psilocybin: A systematic and comprehensive review of neuroimaging studies in humans
Psilocybin is a psychedelic serotonergic compound that is renowned for its potent psychoactive effects. Over the past 15 years, an increasing number o…
www.sciencedirect.com
June 8, 2025 at 7:22 PM
Yesterday, it was the first edition of the National Symposium of the #Psychedelic Medicine Section of the AFPBN and it was a huge success!!

🌟 Stars of the field shared with us the latest news, "avant première" results from French and international research, opening inspiring perspectives.
June 6, 2025 at 5:29 PM
🍿 Carton plein !!
Notre symposium du 5 juin sur la #médecine #psychédélique affiche COMPLET pour le présentiel !
Il est encore possible de vous inscrire pour suivre l'événement dans sa version #distancielle en cliquant sur ce lien ➡️ www.comtoevidence.com/evenement/93/
May 29, 2025 at 9:01 AM
✨ J'ai eu le plaisir d'être invitée par Camille Teste pour un épisode du podcast #EncoreHeureux @bingeaudio.bsky.social sur les #psychédéliques.

www.binge.audio/podcast/enco...
binge.audio
Le réseau de podcast nouvelle génération
www.binge.audio
May 7, 2025 at 5:45 PM
🌿 Bon 1er mai !
L'occasion de lire une interview publiée dans @liberation.fr il y a quelques jours sur les #psychédéliques : www.liberation.fr/societe/rech...

Deux autres articles lui sont associés 👇

Merci @margauxgable.bsky.social !
Recherche sur la médecine psychédélique : «En France, on est hélas un peu à la traîne par rapport à nos voisins»
Selon la psychiatre et chercheuse en neurosciences Lucie Berkovitch, les idées reçues sur les substances dites psychédéliques ont la vie dure en France. Malgré les freins, les études sur le sujet se m...
www.liberation.fr
May 1, 2025 at 1:08 PM
🎧 Merci à Michaëla Cancela-Kieffer de m'avoir fait participer au podcast @afpfr.bsky.social "Sur le fil" sur les thérapies psychédéliques avec l'émouvant témoignage de Julie Dachez : podcasts.afp.com/afp-audio-su...
Thérapies psychédéliques : des débuts prometteurs ?
Des livres, une série documentaire sur Netflix, des récits de voyageurs qui ont testé et des adeptes y compris au plus haut sommet de l’Etat aux Etats-Unis : ...
podcasts.afp.com
April 17, 2025 at 8:39 AM
📣 🌈 🩺 Pétition et tribune dans @lemonde.fr : "Avant de mourir, peut-on mieux vivre ? Pour un accès compassionnel aux psychédéliques en fin de vie" par la Section Médecine Psychédélique de l'AFPBN
Signez la pétition
Pour un accès compassionnel aux traitements psychédéliques en fin de vie
https://www.change.org/traitements_psychédéliques_findevie
April 7, 2025 at 3:20 PM
Reposted by Lucie Berkovitch
Hi everyone, if you are interested in #psychedelic-assisted therapy, we just published a new study: www.sciencedirect.com/science/arti.... Congratulations to Dr. Nathalie Rieser, who has done a terrific job spearheading this project.
Psilocybin-assisted therapy for relapse prevention in alcohol use disorder: a phase 2 randomized clinical trial
Despite the promising therapeutic effects of psilocybin, its efficacy in preventing relapse after withdrawal treatment for alcohol use disorder (AUD) …
www.sciencedirect.com
March 15, 2025 at 10:24 AM
📣📣📣 I am very happy to announce the first edition of the National Symposium of the #Psychedelic Medicine Section of the #AFPBN, taking place on Thursday, June 5th, 2025, at the Paris Brain Institute.
www.afpbn.org/1st-national...
1st National Symposium of the Psychedelic Medicine Section - AFPBN
SCHEDULE OF THE DAY Click here to discover the program Click here to register ! Date : June 5, 2025 Location : Paris Brain Institute, 47 boulevard de l’Hôpital, 75013 PARIS The 1st National Symposium ...
www.afpbn.org
March 9, 2025 at 2:55 PM
January 4, 2025 at 9:01 AM